Cytodyn due for a pop into October

OTC:CYDY   CytoDyn Inc
CYDY performance has been dismal since the out-of-protocol "hold your horses!" FDA letter in late May, continuing down in a withering C wave. A great article posted by our friends KenChowder and ohm on Democrat blog yesterday was angrily removed by complainers conditioned to treat any good news on therapeutics as crazy Trumpist propaganda from the horse dewormer crowd. None of the great results coming in on cancer or NASH or COVID in Philippines is priced in. I think we've wallowed in bad news long enough and this week will have marked a slow rounded bottom at $1.23 with a pop to test the $2.75 apex of the purple wedge in October BEFORE the shareholder meeting and 13D standoff completes.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.